Citations

Clear

6273 citation(s) found for "To, Andrew".

THE EFFECT OF FREEZING ON BIOMECHANICAL PROPERTIES OF THE CARPAL TUNNEL SUBSYNOVIAL CONNECTIVE TISSUE
Filius, Anika , Thoreson, Andrew R. , Dharan, Abhishek, Mara, Kristin C. , An, Kai‐Nan , Zhao, Chunfeng , Amadio, Peter C. , Mara, Kristin C

Mayo Clinic

Journal of Musculoskeletal Research | April 7, 2016 | Volume: 18 | Issue: 04 | Pages: 1550019

10.1142/s0218957715500190 Get It

Biomechanical evaluation of the subsynovial connective tissue (SSCT) provides insight into the causes of carpal tunnel syndrome. Studies of carpal tunnel mechanics have been performed using fresh-frozen cadaver tissue. Freezing can affect mechanical properties of some tissues, but its effect on SSCT is unknown. A total of 16 rabbit paws were harvested from eight New Zealand rabbits and subjected to mechanical testing consisting of three repeated tendon excursions in sets of three different excursion magnitudes. One paw from each animal was unfrozen. The contralateral paw was frozen and thawed before testing. Force, energy and stiffness of the first cycle of each set were evaluated, as were ratios of the second to first cycle for each parameter. Two-factor ANOVA with repeated measures over both factors was performed. No significant interactions between factors were found. There were no significant differences between fresh and frozen paws for any parameters, though there were significant differences between excursion amplitudes. The damage threshold was not different between fresh and frozen paws. This study demonstrated that freezing rabbit subsynovial connective tissue does not significantly change its mechanical properties. The same may be true for human cadaver tissues. Results of cadaver mechanical testing may not be influenced by this preservation technique.
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Shaffer, Brian C. , Ahn, Kwang Woo , Hu, Zhen‐Huan , Malone, Adriana K. , Valcárcel, David , Hamilton, Betty K. , Kharfan‐Dabaja, Mohamed A. , Saad, Ayman , Warlick, Erica D. , Wirk, Baldeep , Sabloff, Mitchell , Fasan, Omotayo , Gerds, Aaron T. , Marks, David I. , Olsson, Richard F. , Wood, William A. , Costa, Luciano J. , Miller, Alan M. , Cortes, Jörge E. , Daly, Andrew , Kindwall‐Keller, Tamila L. , Kamble, Rammurti T., Rizzieri, David A. , Cahn, Jean‐Yves , William, Basem M. , Litzow, Mark R. , Wiernik, Peter H. , Vij, Ravi , Üstün, Celalettin , Copelan, Edward A. , Kalaycio, Matt, Alyea, Edwin P. , Sobecks, R., Pavletic, Steven Z. , Tallman, Martin S. , Saber, Wael , Nishihori, Taiga , Bacher, Ulrike , Hamilton, Betty, Kharfan-Dabaja, Mohamed A., Cutler, Corey, Warlick, Erica, Wirk, Baldeep Mona, Marks, David, Olsson, Richard, Wood, William Allen, Cortes, Jorge, Kindwall-Keller, Tamila L, Kamble, Rammurti, William, Basem, Savani, Bipin N. , Copelan, Edward, Popat, Uday, Maziarz, Richard, Alyea, Edwin, Sobecks, Ron, Pavletic, Steven, Tallman, Martin, Grunwald, Michael R. , Cutler, Corey S. , Reshef, Ran , Gale, Robert Peter , Liesveld, Jane L. , Popat, Uday R , Maziarz, Richard Thomas , Gerds, Aaron T , Saad, Ayman , Olsson, Richard F , Cortes, Jorge , William, Basem , Costa, Luciano J , Sabloff, Mitchell , Wood, William A , Valcárcel, David

Mayo Clinic

Journal of Clinical Oncology | April 5, 2016 | Volume: 34 | Issue: 16 | Pages: 1864-1871

10.1200/jco.2015.65.0515 | PMID 27044940 Get It

Purpose To develop a system prognostic of outcome in those undergoing allogeneic hematopoietic cell transplantation (allo HCT) for myelodysplastic syndrome (MDS). Patients and Methods We examined 2,133 patients with MDS undergoing HLA-matched (n = 1,728) or -mismatched (n = 405) allo HCT from 2000 to 2012. We used a Cox multivariable model to identify factors prognostic of mortality in a training subset (n = 1,151) of the HLA-matched cohort. A weighted score using these factors was assigned to the remaining patients undergoing HLA-matched allo HCT (validation cohort; n = 577) as well as to patients undergoing HLA-mismatched allo HCT. Results Blood blasts greater than 3% (hazard ratio [HR], 1.41; 95% CI, 1.08 to 1.85), platelets 50 × 109/L or less at transplantation (HR, 1.37; 95% CI, 1.18 to 1.61), Karnofsky performance status less than 90% (HR, 1.25; 95% CI, 1.06 to 1.28), comprehensive cytogenetic risk score of poor or very poor (HR, 1.43; 95% CI, 1.14 to 1.80), and age 30 to 49 years (HR, 1.60; 95% CI, 1.09 to 2.35) were associated with increased hazard of death and assigned 1 point in the scoring system. Monosomal karyotype (HR, 2.01; 95% CI, 1.65 to 2.45) and age 50 years or older (HR, 1.93; 95% CI, 1.36 to 2.83) were assigned 2 points. The 3-year overall survival after transplantation in patients with low (0 to 1 points), intermediate (2 to 3), high (4 to 5) and very high (≥ 6) scores was 71% (95% CI, 58% to 85%), 49% (95% CI, 42% to 56%), 41% (95% CI, 31% to 51%), and 25% (95% CI, 4% to 46%), respectively (P < .001). Increasing score was predictive of increased relapse (P < .001) and treatment-related mortality (P < .001) in the HLA-matched set and relapse (P < .001) in the HLA-mismatched cohort. Conclusion The proposed system is prognostic of outcome in patients undergoing HLA-matched and -mismatched allo HCT for MDS.
A Systematic Review and Expert Opinion of Preferred Reconstructive Techniques after Enbloc Spinal Column Tumor Resection
Dea, Nicolas , Rhines, Laurence D. , Sciubba, Daniel M. , Verlaan, Jorrit‐Jan , Gokaslan, Ziya L. , Fisher, Charles G. , Glennie, Andrew , Ailon, Tamir T. , Bettegowda, Chetan , Clarke, Michelle J.

Mayo Clinic

Global Spine Journal | April 4, 2016 | Volume: 6 | Issue: 1_suppl | Pages: s-0036-1583024-s-0036-1583024

10.1055/s-0036-1583024 Get It

Introduction Primary tumors of the spine requiring enbloc resection are rare. Most published reports are small and focus on disease free survival and recurrence rates. Very few studies focus on the various anterior and posterior reconstructive options and subsequent outcomes with respect to fusion rates and need for revision due to hardware failure. The objective of this review was to (1) summarize the published literature and (2) report the failure rates of various anterior and posterior reconstructive techniques after enbloc resection of spinal tumors and (3) supplement the deficiencies in the available published literature with expert opinion for reconstructive options from a group of experienced international spine tumor surgeons. Material and Methods An electronic search of the literature was undertaken from January 1990 – December 2013 evaluating specific reconstructive techniques of the spine after primary tumor enbloc resection. Prospective/retrospective trials and case series were included in the final analysis when fusion rates or failure rates were reported. The data available for each reconstructive technique was then combined and construct survivorship was summarized. In addition, a questionnaire was administered to a group of 20 international spine tumor surgeons evaluating specific reconstructive preferences at different regions of the spine based on the number of vertebrae resected and whether post-operative radiation was planned. Results The initial search yielded 381 articles with 31 subsequently included for full text review. Fourteen articles were included in the final analysis. There were 146 patients included for final review. There were 2/9 (22%) patients revised from short to long segment constructs and 3 reports of broken pedicle screws with only one requiring revision in longer constructs. Rates of revision for anterior reconstruction were similar for autogenous strut grafts (10%), cages (7.7%) and allograft strut grafts (8.3%). No surgeons responding to the questionnaire recommended short segment posterior constructs. For anterior reconstruction, cages packed with morcellized allograft and autograft were preferred (75%, p < 0.05) while strut bone grafting was choosen more often at the cervicothoracic junction (65%, p < 0.05) and when more than one vertebrae was resected in the mid thoracic spine (75%, p < 0.05). Few surgeons changed their anterior reconstructive technique (15%) or posterior reconstructive technique (10%) when post-operative radiation was planned. Conclusion The literature and consensus opinion supports posterior reconstruction with at least two vertebral levels of support above and below. For anterior vertebral column reconstruction, structural allograft, autograft and cages packed with morcelized bone have shown similar rates of fusion and failure. Expert opinion, however, suggests that structural autograft or potentially vascularized strut grafts should be used when spanning a defect greater than 2 vertebral bodies especially at the cervicothoracic junction.
White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network
Lee, Seonjoo , Viqar, Fawad, Zimmerman, Molly E. , Narkhede, Atul, Benzinger, Tammie L.S. , Marcus, Daniel S. , Fagan, Anne M. , Goate, Alison , Fox, Nick C. , Cairns, Nigel J., Buckles, Virginia, Martins, Ralph N. , Saykin, Andrew J. , Masters, Colin L. , Ringman, John M. , Ryan, Natalie S. , Förster, Stefan , Laske, Christoph , Schofield, Peter R. , Salloway, Stephen , Correia, Stephen , Jack, Clifford R. , Weiner, Michael W. , Bateman, Randall J. , Morris, John C. , Mayeux, Richard , Network, for the Dominantly Inherited Alzheimer, Tosto, Giuseppe , Holtzman, David M. , Ghetti, Bernardino , McDade, Eric , Sperling, Reisa Anne , Brickman, Adam M. , Network, for the Dominantly Inherited Alzheimer, Jack, Clifford R , Saykin, Andrew J , Schofield, Peter R , Bateman, Randall J , Masters, Colin L , Benzinger, Tammie L S , Fox, Nick C , Morris, John C , Goate, Alison M

Mayo Clinic

Annals of Neurology | March 26, 2016 | Volume: 79 | Issue: 6 | Pages: 929-939

10.1002/ana.24647 | PMID 27016429 Get It

ObjectiveWhite matter hyperintensities (WMHs) are areas of increased signal on T2‐weighted magnetic resonance imaging (MRI) scans that most commonly reflect small vessel cerebrovascular disease. Increased WMH volume is associated with risk and progression of Alzheimer's disease (AD). These observations are typically interpreted as evidence that vascular abnormalities play an additive, independent role contributing to symptom presentation, but not core features of AD. We examined the severity and distribution of WMH in presymptomatic PSEN1, PSEN2, and APP mutation carriers to determine the extent to which WMH manifest in individuals genetically determined to develop AD.MethodsThe study comprised participants (n = 299; age = 39.03 ± 10.13) from the Dominantly Inherited Alzheimer Network, including 184 (61.5%) with a mutation that results in AD and 115 (38.5%) first‐degree relatives who were noncarrier controls. We calculated the estimated years from expected symptom onset (EYO) by subtracting the affected parent's symptom onset age from the participant's age. Baseline MRI data were analyzed for total and regional WMH. Mixed‐effects piece‐wise linear regression was used to examine WMH differences between carriers and noncarriers with respect to EYO.ResultsMutation carriers had greater total WMH volumes, which appeared to increase approximately 6 years before expected symptom onset. Effects were most prominent for the parietal and occipital lobe, which showed divergent effects as early as 22 years before estimated onset.InterpretationAutosomal‐dominant AD is associated with increased WMH well before expected symptom onset. The findings suggest the possibility that WMHs are a core feature of AD, a potential therapeutic target, and a factor that should be integrated into pathogenic models of the disease. Ann Neurol 2016;79:929–939
Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions: a systematic review with recommendations for prophylaxis
Santiago, Tania M. González, Wetter, David A. , Kalaaji, Amer N., Lehman, Julia S. , Gonzalez Santiago, Tania M, Limper, Andrew H. , Lehman, Julia S

Mayo Clinic

International Journal of Dermatology | March 24, 2016 | Volume: 55 | Issue: 8 | Pages: 823-830

10.1111/ijd.13231 | PMID 27009930 Get It

SummaryPneumocystis jiroveci pneumonia is an opportunistic infection associated with substantial rates of mortality in immunosuppressed patients. Prophylaxis recommendations are mostly targeted toward patients with non‐dermatologic diagnoses. This study was conducted to determine when dermatology patients treated with immunosuppressive medications should be offered P. jiroveci pneumonia prophylaxis. We searched the literature from January 1, 1993, to December 31, 2013, using terms relating to P. jiroveci pneumonia and dermatologic diagnoses to analyze the clinical characteristics of previously affected patients. Guidelines for P. jiroveci pneumonia prophylaxis from other medical fields were also analyzed. Of 17 dermatology patients reported to have contracted P. jiroveci pneumonia, eight (47.1%) died of the pneumonia. Risk factors included lack of prophylaxis, systemic corticosteroid therapy, lymphopenia, hypoalbuminemia, low serum CD4 counts, comorbid pulmonary or renal disease, malignancy, and prior organ transplantation. The present conclusions are limited by heterogeneity among the selected studies and limitations in their identification and selection. However, P. jiroveci pneumonia in dermatology patients is associated with a high mortality rate. Based on our analysis, we propose that prophylaxis be considered in dermatology patients in whom treatment with systemic corticosteroids at doses exceeding 20 mg/day or treatment with corticosteroid‐sparing immunosuppressive agents is anticipated for at least 4 weeks, and in patients with additional risk factors for P. jiroveci pneumonia.
A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway
Song, Jung Min, Sung, You Me, Nam, Jin Han , Yoon, Hyejin , Chung, Andrew J., Moffat, Emily, Jung, Mira , Pak, Daniel T.S. , Kim, Jungsu , Hoe, Hyang-Sook, Kim, Jungsu

Mayo Clinic

Journal of Alzheimer's Disease | March 16, 2016 | Volume: 51 | Issue: 2 | Pages: 591-604

10.3233/jad-150717 | PMID 26890742 Get It

Diffuse Pulmonary Lymphangiomatosis
Kadakia, Kunal C. , Patel, Sandeep M. , Yi, Eunhee S. , Limper, Andrew H.

Mayo Clinic

Canadian Respiratory Journal | March 15, 2016 | Volume: 20 | Issue: 1 | Pages: 52-54

10.1155/2013/971350 | PMID 23457676 Get It

Diffuse pulmonary lymphangiomatosis (DPL) is a rare disease characterized by infiltration of the lung, pleura and mediastinum with thin-walled lymphangiomas. DPL can result in mass effect from infiltrative disease, restrictive and obstructive pulmonary physiology, chylous effusions and respiratory failure. The present article discusses clinical, radiographic and pathological features, and treatment options for DPL.
Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors
Usset, Joseph , McGuire, Valerie , Sieh, Weiva , Webb, Penelope M. , Chang‐Claude, Jenny, Brinton, Louise A. , Cunningham, Julie M. , DeFazio, Anna , Edwards, Robert P., Gayther, Simon A. , Goodman, Marc T. , Høgdall, Estrid , Jensen, Allan , Johnatty, Sharon E., Lurie, Galina, Massuger, Leon F.A.G. , Menon, Usha , Moysich, Kirsten B. , Ness, Roberta B., Pike, Malcolm C. , Ramus, Susan J. , Rossing, Mary Anne, Rothstein, Joseph H. , Song, Honglin , Thompson, Pamela J., Berg, David J. Van Den, Vierkant, Robert A. , Wang‐Gohrke, Shan , Wentzensen, Nicolas , Whittemore, Alice S. , Wu, Anna H. , Pearce, Celeste Leigh, Schildkraut, Joellen M. , Goode, Ellen L. , Fazio, Anna de , Raghavan, Rama , Tyrer, Jonathan P. , Rudolph, Anja , Anton‐Culver, Hoda , Berchuck, Andrew , Doherty, Jennifer A. , Gentry‐Maharaj, Aleksandra , Kiemeney, Lambertus A. , Kjær, Susanne K. , Larson, Melissa C. , Modugno, Francesmary , Wilkens, Lynne R. , Yang, Hannah , Pharoah, Paul D.P. , Fridley, Brooke L. , Ramus, Susan J , Webb, Penelope M , Jensen, Allan , Vierkant, Robert A , Menon, Usha , Moysich, Kirsten , Sieh, Weiva , Høgdall, Estrid , Goodman, Marc T

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | March 14, 2016 | Volume: 25 | Issue: 5 | Pages: 780-790

10.1158/1055-9965.epi-15-1039 | PMID 26976855 Get It

Abstract Background: Many epithelial ovarian cancer (EOC) risk factors relate to hormone exposure and elevated estrogen levels are associated with obesity in postmenopausal women. Therefore, we hypothesized that gene–environment interactions related to hormone-related risk factors could differ between obese and non-obese women. Methods: We considered interactions between 11,441 SNPs within 80 candidate genes related to hormone biosynthesis and metabolism and insulin-like growth factors with six hormone-related factors (oral contraceptive use, parity, endometriosis, tubal ligation, hormone replacement therapy, and estrogen use) and assessed whether these interactions differed between obese and non-obese women. Interactions were assessed using logistic regression models and data from 14 case–control studies (6,247 cases; 10,379 controls). Histotype-specific analyses were also completed. Results: SNPs in the following candidate genes showed notable interaction: IGF1R (rs41497346, estrogen plus progesterone hormone therapy, histology = all, P = 4.9 × 10−6) and ESR1 (rs12661437, endometriosis, histology = all, P = 1.5 × 10−5). The most notable obesity–gene–hormone risk factor interaction was within INSR (rs113759408, parity, histology = endometrioid, P = 8.8 × 10−6). Conclusions: We have demonstrated the feasibility of assessing multifactor interactions in large genetic epidemiology studies. Follow-up studies are necessary to assess the robustness of our findings for ESR1, CYP11A1, IGF1R, CYP11B1, INSR, and IGFBP2. Future work is needed to develop powerful statistical methods able to detect these complex interactions. Impact: Assessment of multifactor interaction is feasible, and, here, suggests that the relationship between genetic variants within candidate genes and hormone-related risk factors may vary EOC susceptibility. Cancer Epidemiol Biomarkers Prev; 25(5); 780–90. ©2016 AACR.
Fungal, Viral, and Parasitic Pneumonias Associated with Human Immunodeficiency Virus
Skalski, Joseph H. , Limper, Andrew H.

Mayo Clinic

Seminars in Respiratory and Critical Care Medicine | March 14, 2016 | Volume: 37 | Issue: 02 | Pages: 257-266

10.1055/s-0036-1578802 | PMID 26974302 Get It